Related Experiment Video
Updated: May 4, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Pancytopenia secondary to cytomegalovirus reactivation
1David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Insights
Cytomegalovirus (CMV) reactivation caused isolated pancytopenia in a patient with microscopic polyangiitis. Prompt ganciclovir treatment led to complete blood count recovery, demonstrating effective CMV management.
Area of Science:
- Infectious Diseases
- Hematology
- Immunology
Background:
- Microscopic polyangiitis (MPA) is a systemic vasculitis often treated with immunosuppressive agents.
- Immunosuppression increases the risk of opportunistic infections, such as cytomegalovirus (CMV).
Observation:
- A 64-year-old woman with MPA presented with a severe leg ulcer and developed pancytopenia.
- Her immunosuppressive regimen included prednisone, azathioprine, cyclophosphamide, and rituximab.
- Diagnostic work-up revealed cytomegalovirus (CMV) reactivation as the cause of pancytopenia, with viral load at 899,100 copies/mL.
Findings:
- Treatment with intravenous ganciclovir, followed by an oral regimen, was initiated.
- The patient showed a significant response to antiviral therapy.
- Complete hematologic recovery was observed, with normalization of white blood cell count, hemoglobin, and platelet count.
Implications:
- This case highlights the importance of considering opportunistic infections like CMV reactivation in immunosuppressed patients presenting with cytopenias.
- Early diagnosis and prompt antiviral treatment are crucial for managing CMV-induced pancytopenia.
- Effective management of CMV reactivation can lead to full hematologic recovery in immunocompromised individuals.
Abstract:
A 64-year-old woman with a 1-year history of microscopic polyangiitis developed isolated pancytopenia secondary to cytomegalovirus (CMV) reactivation. The patient was originally admitted to the medical service for the management of a rapidly progressing 10 cm ulcer on her left lower extremity. Prior to admission, the patient had been on several immunosuppressive agents for the treatment of microscopic polyangiitis, including prednisone, azathioprine, cyclophosphamide and rituximab. Her hospital course was notable for pancytopenia and after a very thorough diagnostic work-up, the aetiology was found to be secondary to CMV reactivation. This was confirmed by blood analysis that revealed a highly elevated CMV level at 899 100 copies/mL by quantitative PCR. The patient was promptly treated with intravenous ganciclovir for a total course of 14 days before transitioning to an oral regimen. She had a pronounced response to the anti-CMV therapy with complete recovery of her white cell count, haemoglobin and platelet count to baseline.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Hypersensitivity Reactions: Cytolytic Reactions
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Myocarditis III: Medical Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

